Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Results from the RAPID-MIRACLE trial have found, for the first time, that the widely used MIRACLE 2 risk score can be applied outside a hospital setting to accurately predict brain injury following a ...
A new study in the journal Pediatrics has demonstrated an algorithm to evaluate when children with chest pain should be referred for further diagnosis. Pediatric chest pain is seldom due to heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results